Titlebook: Breast Cancer Management for Surgeons; An Examination Guide Christos Markopoulos,Andreas Karakatsanis Textbook 2023 The Editor(s) (if appli

blister

Breast Conservation Surgeryn to normal function than mastectomy (with or without reconstruction). Achievement of clear margins with even cT3 tumours or large volumes of DCIS with ever larger tumour to breast volume ratios has become possible owing to the development and increasing availability of oncoplastic methods including

慟哭

Mastectomy: Reconstructive Considerations and Strategiese disease when feasible to achieve oncological adequate margins and maintain the breast aesthetic. Despite advances in oncoplastic techniques and the increasing use of neoadjuvant systemic therapies that may broaden the scope of breast conservation, mastectomy is still playing an important role in b

終止

Axillary Surgery for Early Breast Cancerodal status is a strong prognosticator, next to primary tumor size and grade. Hence, axillary staging remains the standard of care for all breast cancers amenable to curative treatment. Initially, axillary surgery was viewed as a procedure that had a therapeutic effect and, initially, major and aggr

寡頭政治

Principles of Primary Systemic Therapy and targeted drugs, including endocrine therapy and HER2-targeting antibodies for ER-positive and HER2-positive BC, respectively. Although systemic therapies were initially developed post-operatively (adjuvant), their use has later expanded to the primary, pre-operative setting (neoadjuvant or prim

移動(dòng)

恃強(qiáng)凌弱

性別

刺穿

Flat-Feet

Biopolitics — Imagining Victimhoodis the leading cause of cancer deaths among women (Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A, CA Cancer J Clin. 68:394–424, 2018). The incidence of BC has been steadily rising over the past 20?years, this increase can, in part, be explained by increased case finding due to scre

匍匐

Individuation — Acting on Victimhoodandomized controlled trials conducted in the past 40?years have established a reduction in the mortality rate of 25%–30%. A large Swedish study found a reduction by 41% in fatal cancers and by 25% in the incidence of advanced breast cancers within ten years, in women undergoing mammographic screenin